Exchange Traded Concepts, LLC Tg Therapeutics, Inc. Transaction History
Exchange Traded Concepts, LLC
- $10.4 Billion
- Q3 2025
A detailed history of Exchange Traded Concepts, LLC transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Exchange Traded Concepts, LLC holds 25,063 shares of TGTX stock, worth $880,212. This represents 0.01% of its overall portfolio holdings.
Number of Shares
25,063Holding current value
$880,212% of portfolio
0.01%Shares
2 transactions
Others Institutions Holding TGTX
# of Institutions
408Shares Held
91.9MCall Options Held
2.28MPut Options Held
1.78M-
Vanguard Group Inc Valley Forge, PA15.8MShares$555 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$400 Million0.0% of portfolio
-
State Street Corp Boston, MA7.62MShares$268 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA3.49MShares$123 Million0.01% of portfolio
-
Clearbridge Investments, LLC New York, NY3.05MShares$107 Million0.09% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $5.1B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...